definiens: shallmean, with regard to [COMPANY] as the Conducting Party, allowing the applicable Regulatory Authorityin a country to have access to relevant information ( by cross - reference, incorporation byreference or otherwise ) contained in Regulatory Documentation ( and any data contained therein)filed with such Regulatory Authority with respect to the [COMPANY] Compound ( and, in the case ofBMS as the Non - Conducting Party, the Right to Cross - Reference the Combined Therapy IND),only to the extent necessary for the conduct of a Combined Therapy Trial in such country or asotherwise expressly permitted or required under the Agreement and/or this Supplement to enableBMS to exercise its rights or perform its obligations under the Agreement and/or this Supplement, and, except as to information contained in the Combined Therapy IND relating to the CombinedTherapy, without the disclosure of such information to [COMPANY]